Barriers and Enablers to Diabetic Retinopathy Screening: a Cross-sectional Survey of Young Adults with Type 1 and Type 2 Diabetes in the UK
Overview
Authors
Affiliations
Introduction: Diabetic retinopathy screening (DRS) attendance in young adults (YAs) is consistently below recommended levels. The aim of this study was to identify barriers and enablers of DRS attendance among YAs in the UK living with type 1 (T1D) and type 2 diabetes (T2D).
Research Design And Methods: YAs (18-34 years) were invited to complete an anonymous online survey in June 2021 assessing agreement with 30 belief statements informed by the Theoretical Domains Framework (TDF) of behavior change describing potential barriers/enablers to DRS.
Results: In total, 102 responses were received. Most had T1D (65.7%) and were regular attenders for DRS (76.5%). The most salient TDF domains for DRS attendance were '', with 93% agreeing that DRS was a high priority, and '', with 98% being aware that screening can detect eye problems early.Overall, 67.4% indicated that they would like greater appointment flexibility ) and 31.3% reported difficulties getting time off work/study to attend appointments ). This was more commonly reported by occasional non-attenders versus regular attenders (59.1% vs 23.4%, p=0.002). Most YAs were worried about diabetic retinopathy (74.3%), anxious when receiving screening results (63%) () and would like more support after getting their results (66%) (). Responses for T1D and T2D were broadly similar, although those with T2D were more likely have developed strategies to help them to remember their appointments (63.6% vs 37.9%, p=0.019) ().
Conclusions: Attendance for DRS in YAs is influenced by complex interacting behavioral factors. Identifying modifiable determinants of behavior will provide a basis for designing tailored interventions to improve DRS in YAs and prevent avoidable vision loss.
Validation of a Deep Learning Model for Diabetic Retinopathy on Patients with Young-Onset Diabetes.
Tan-Torres 3rd A, Praveen P, Jeji D, Brant A, Yin X, Yang L Ophthalmol Ther. 2025; .
PMID: 40087218 DOI: 10.1007/s40123-025-01116-z.
Liu T, Wolf R Diabetes Spectr. 2025; 38(1):19-22.
PMID: 39959516 PMC: 11825398. DOI: 10.2337/dsi24-0016.
Banks J, Olvera-Barrios A, Pitt M, Williams D, Seltene M, Rutowska C BMJ Open Ophthalmol. 2025; 10(1).
PMID: 39843349 PMC: 11759212. DOI: 10.1136/bmjophth-2024-001969.
Adherence to diabetic retinopathy screening among children and young adults in Bangladesh.
Curran K, Ahmed M, Sultana M, Moutari S, Hossain M, Cushley L Clin Diabetes Endocrinol. 2024; 10(1):41.
PMID: 39627896 PMC: 11616320. DOI: 10.1186/s40842-024-00208-2.
Yelagondula V, Marmamula S, Varada R, Subramanian A, Lawrenson J Ophthalmic Physiol Opt. 2024; 45(2):450-457.
PMID: 39602082 PMC: 11823384. DOI: 10.1111/opo.13424.